EGFR-INHIBITOREN

Patent europeic · EP4076665 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4076665
Numer da la dumonda
EP20835790
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
18-12-2020
Publitgà
26-10-2022
Concedì
30-08-2023
La protecziun finescha il pli tard
17-12-2040
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61P 35/00 (2006.01)
C07D 487/04 (2006.01)
A61K 31/454 (2006.01)
A61K 31/427 (2006.01)
A61K 31/55 (2006.01)
Prioritad
EP 19218390 20.12.2019
Dumonda PCT
PCT/EP2020/086917 18.12.2020
Publicaziun PCT
WO2021/123087 24.06.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 10-07-2024

    Midada

    Published in Swissreg on 10.07.2024

  4. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  5. 30-08-2023

    Concedì

    Published in Swissreg on 30.08.2023

Partidas

Possessur

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventur

JAESCHKE, Georg

4070 Basel

NAGEL, Yvonne Alice

4070 Basel

KUHN, Bernd

4070 Basel

HEWINGS, David Stephen

4070 Basel

RICCI, Antonio

4070 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.